The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Brief Title: A Study of Verutex (Fusidic Acid), Eritex (Erythromycin) and Fisiogel in the Management of Tarceva-Associated Rash.
Official Title: A Randomized, Open Label Study to Compare the Use of the Dermatological Creams Verutex, Eritex and Fisiogel in the Management of Skin Rash Associated With Tarceva Treatment in Patients With Locally Advanced or Metastatic Non-small Cell Lung Cancer.
Study ID: NCT00718315
Brief Summary: This 3 arm study will compare the efficacy and safety of three different dermatological creams designed for prophylaxis of skin rash associated with Tarceva treatment in patients with locally advanced or metastatic non-small cell lung cancer. Eligible patients who have recently started Tarceva treatment will be randomized to one of 3 groups, to receive daily treatment with Verutex, Eritex or Fisiogel cream for 30 days, and the incidence and severity of skin rash will be assessed. The anticipated time on study treatment is \<3 months, and the target sample size is 100-500 individuals.
Detailed Description:
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
, Salvador, BA, Brazil
, Salvador, BA, Brazil
, Salvador, BA, Brazil
, Fortaleza, CE, Brazil
, Fortaleza, CE, Brazil
, Taguatinga, DF, Brazil
, Goiania, GO, Brazil
, Belo Horizonte, MG, Brazil
, Belo horizonte, MG, Brazil
, Divinopolis, MG, Brazil
, Recife, PE, Brazil
, Curitiba, PR, Brazil
, Curitiba, PR, Brazil
, Rio de Janeiro, RJ, Brazil
, Rio De Janeiro, RJ, Brazil
, Natal, RN, Brazil
, Ijui, RS, Brazil
, Porto Alegre, RS, Brazil
, Itajai, SC, Brazil
, Ribeirao Preto, SP, Brazil
, Sao Paulo, SP, Brazil
, Sao Paulo, SP, Brazil
, Sao Paulo, SP, Brazil
, Sao Paulo, SP, Brazil
, Sao Paulo, SP, Brazil
, Sao Paulo, SP, Brazil
Name: Clinical Trials
Affiliation: Hoffmann-La Roche
Role: STUDY_DIRECTOR